4-{(2Z)-2-[(2Z,8xi,9xi,14xi,16alpha,17beta)-16,17-dihydroxy-3-oxoestra-1(10),4-dien-2-ylidene]hydrazinyl}benzoic acid (57266-76-9)

Identification
Name:	4-{(2Z)-2-[(2Z,8xi,9xi,14xi,16alpha,17beta)-16,17-dihydroxy-3-oxoestra-1(10),4-dien-2-ylidene]hydrazinyl}benzoic acid
Synonyms:	LogP
CAS:	57266-76-9
Molecular Formula:	C₂₅H₂₈N₂O₅
Molecular Weight:	436.5002
InChI:	InChI=1/C25H28N2O5/c1-25-9-8-16-17(19(25)12-22(29)23(25)30)7-4-14-10-21(28)20(11-18(14)16)27-26-15-5-2-13(3-6-15)24(31)32/h2-3,5-6,10-11,16-17,19,22-23,26,29-30H,4,7-9,12H2,1H3,(H,31,32)/b27-20-/t16?,17?,19?,22-,23+,25+/m1/s1
Molecular Structure:
Properties
Flash Point:	360.873°C
Boiling Point:	673.092°C at 760 mmHg
Density:	1.493g/cm³
Refractive index:	1.722
Flash Point:	360.873°C
Safety Data

Other Product

4-{(2Z)-2-[(4Z,8xi,9xi,14xi,16alpha,17beta)-16,17-dihydroxy-3-oxoestra-1,5(10)-dien-4-ylidene]hydrazinyl}benzoic acid
(8xi,9xi,13xi,14xi,17beta)-17-hydroxy-3-oxoestra-1,4-dien-10-yl acetate
(2beta,3alpha,5alpha,8xi,9xi,14xi,16beta,17beta)-17-(acetyloxy)-3-hydroxy-16-(1-methylpiperidinium-1-yl)-2-(morpholin-4-yl)androstane
(8xi,9xi,14xi,17beta)-17-hydroxyestra-1,3,5(10)-trien-3-yl benzoate - pregn-4-ene-3,20-dione (1:1)
(17beta)-3-oxoandrost-4-en-17-yl heptanoate - (8xi,9xi,14xi,17beta)-3-hydroxyestra-1,3,5(10)-trien-17-yl pentanoate (1:1)
disodium (8xi,9xi,11beta,14xi,16alpha)-9-fluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl phosphate (9xi,11beta,16alpha)-9-fluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl 3-phenylpropanoate (1:1)
(8xi,9xi,14xi,17beta)-4-chloro-3-oxoandrost-4-en-17-yl nitrate
3-{[(8xi,9xi,14xi,15beta,17beta)-17-hydroxy-3-oxoandrost-4-en-15-yl]sulfanyl}propanoic acid
(2alpha,5alpha,8xi,9xi,14xi,17beta)-2-methyl-3-oxoandrostan-17-yl hexanoate
(2alpha,5alpha,8xi,9xi,14xi,17beta)-2-methyl-3-oxoandrostan-17-yl heptanoate
(3beta,5alpha,8xi,9xi,14xi,17beta)-3-(1-methylpyrrolidinium-1-yl)androstan-17-ol iodide
({[(3beta,7Z,8xi,9xi,14xi,16alpha)-3,16-dihydroxy-20-oxopregn-5-en-7-ylidene]amino}oxy)acetic acid
N-[(3beta,4alpha,5alpha,8xi,9xi,10xi,14xi,16alpha,20S)-20-(dimethylamino)-16-hydroxy-4-(hydroxymethyl)-4,14-dimethyl-9,19-cyclopregnan-3-yl]-4-hydroxy-3,5-dimethoxybenzamide
2-hydroxy-4-[(2Z)-2-(4-hydroxy-3-methyl-2-oxonaphthalen-1-ylidene)hydrazinyl]benzoic acid
(2beta,3alpha,5alpha,8xi,9xi,14xi,16beta,17beta)-3,17-bis(acetyloxy)-2-piperidin-1-yl-16-(1-prop-2-en-1-ylpiperidinium-1-yl)androstane bromide
(8xi,9xi,14xi,17alpha)-17-hydroxyestra-1,3,5(10)-trien-3-yl beta-D-galactopyranosiduronic acid
(2beta,3alpha,5alpha,8xi,9xi,14xi,16beta,17beta)-3,16-bis(acetyloxy)-N,N,N-trimethyl-2-(1-methylpiperidinium-1-yl)androstan-17-aminium diiodide
7-[(2Z)-2-(2-methyl-4-oxocyclohexa-2,5-dien-1-ylidene)hydrazinyl]naphthalene-1,3-disulfonic acid
4-({(Z)-(6-oxocyclohexa-2,4-dien-1-ylidene)[(2Z)-2-(5-thioxo-1,3,4-thiadiazol-2(5H)-ylidene)hydrazinyl]methyl}amino)benzoic acid
(3alpha,5alpha,8xi,9xi,14xi,17beta)-2,16-bis(1-prop-2-yn-1-ylpiperidinium-1-yl)androstane-3,17-diol dibromide